Key result
Thrombomodulin shows potential as a blood biomarker for thrombosis risk despite low specificity.
Why the study?
Although thrombomodulin has established diagnostic and prognostic value, its clinical utility is limited by low specificity, prompting a review of its structure, functions, current clinical practice, and potential as a thrombosis risk marker.
Design
Review
Authors
Loading...
TM biomarker potential merits prospective validation studies; low specificity precludes routine clinical adoption.
Tanashyan et al. (2025) studied this question. Thrombomodulin (TM) exhibits multimodal properties and holds potential as a blood biomarker for thrombosis risk despite its low specificity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: